|
| Press Releases |
|
 |
|
| Tuesday, August 7, 2012 |
|
|
Q&A: MediciNova CEO, Dr. Yuichi Iwaki on His Firm's Pipeline, Upcoming Milestones and Recent Clinical Trial Results |
| Dr. Yuichi Iwaki, President and CEO of Nasdaq listed small-cap MediciNova, Inc. (NASDAQ:MNOV) took the time to answer BioMedReports' questions about his firm's pipeline, upcoming milestones and recent clinical trial results. more info >> |
|
| Thursday, August 2, 2012 |
|
|
Amicus Therapeutics: Strong Catalyst Trade With GlaxoSmithKline And Heavy Insider Buying |
| I like to invest in and trade companies with strong corporate structures that are also equipped with upcoming short term catalysts. more info >> |
|
|
Doomed Dendreon? Many Speculators Shocked By Poor Sales Again |
| Dendreon (DNDN) has been a disastrous holding for many investors who may have been initially optimistic about the company's drug PROVENGE. more info >> |
|
| Wednesday, August 1, 2012 |
|
|
Former Chairman and CEO of Celgene Believes His New Firm Can Become "A Substantial Player" in Biotech |
| No doubt, one of the biggest biotech surprises out of the starting gate this year has been Medgenics Inc. (AMEX:MDGN). The stock ran big shortly after their introduction to the market as shares traded from $2.08 to $16.43 in short order-- an impressive run fueled in part by the company's extremely low float and excited reaction by investors. more info >> |
|
| Tuesday, July 31, 2012 |
|
|
Pluristem Therapeutics' New Indication for Pulmonary and Lung Disorders Expands Blockbuster Pipeline |
| This morning, Pluristem Therapeutics (NASDAQ:PSTI) is once again making news. This time, with a new way to treat Pulmonary fibrosis; where a person's lungs become so scarred that breathing is impossible. more info >> |
|
|
Pluristem's New Indication for Pulmonary and Lung Disorders Expands Blockbuster Pipeline |
| This morning, Pluristem Therapeutics (PSTI) is once again making news. This time with a new way to treat Pulmonary fibrosis; where a person's lungs become so scarred that breathing is impossible. It strikes 5 million people per year around the world, and 200,000 in the US. Most die because there is no cure. more info >> |
|
| Friday, July 27, 2012 |
|
|
Roth Capital Says Amarin's Approval Provides Visibility for Neptune Reiterates Buy Rating and $10.30 Price Target |
| In a flash note to clients on Friday, Roth Capital Partners' analyst Joseph Pantginis, Ph.D.,says that Thursday's FDA approval for Amarin Corporation's (NASDAQ:AMRN) Vascepa bodes well for Neptune Technologies & Bioressources' (Nasdaq:NEPT) (TSX:NTB) underlying and growing core NKO business as well as the pharmaceutical opportunity with Acasti's CaPre. more info >> |
|
| Thursday, July 26, 2012 |
|
|
Short Squeeze & Speculation Could Push Onyx and Ligand Higher |
| When I last covered Onyx Pharmaceuticals (NASDAQ:ONXX) on June 19th, the company was trading at a market capitalization of approximately $3 billion dollars ahead of a review of Kyprolis (carfilzomib) by the FDA's Oncologic Drugs Advisory Committee (ODAC). more info >> |
|
| Monday, July 23, 2012 |
|
|
Pluristem Poised To Benefit From The Evolution of Regulatory Requirements |
| Trying to find companies that represent the future of the biotech sector can be tricky for investors. The sector currently leads the market because Food and Drug Administration (FDA) regulatory guidance is changing, with restrictions easing, and new guidelines being proposed and implemented. more info >> |
|
|
New Reports Indicate That Brainstorm's Clinical Data is Compelling |
| While BrainStorm Cell Therapeutics (OTCBB:BCLI) is expected to officially release their highly anticipated clinical data to U.S. investors shortly, two widely distributed overnight reports point to strong progress in the results of their mid-stage clinical trials. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
華領醫藥在2025ADA科學年會公佈多格列艾汀與DPP-4抑制劑聯用在恢復血糖穩態的同時有望降低血脂
Jun 23, 2025 21:59 HKT/SGT
|
|
|
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis
Jun 23, 2025 22:57 JST
|
|
|
ZeptoMetrix Launches H5N1 Control With Phage-Like Particle (PLP) Technology
Jun 23, 2025 21:00 HKT/SGT
|
|
|
Executive Appointments in Connection with the Establishment of NESIC Holdings
Jun 23, 2025 19:22 JST
|
|
|
新冠疫情多地爆發 專家呼籲暑假外遊慎提防
Jun 23, 2025 18:07 HKT/SGT
|
|
|
雲知聲在港招股 AGI獨角獸進入IPO衝刺階段
Jun 23, 2025 17:20 HKT/SGT
|
|
|
云知声在港招股 AGI独角兽进入IPO冲刺阶段
Jun 23, 2025 17:20 HKT/SGT
|
|
|
YCP Releases New White Paper on the Shift to Affiliate Marketing in Southeast Asia
Jun 23, 2025 12:00: JST
|
|
|
华领医药在2025ADA科学年会公布多格列艾汀与DPP-4抑制剂联用在恢复血糖稳态的同时有望降低血脂
Jun 23, 2025 11:11 HKT/SGT
|
|
|
YCP Releases New White Paper on the Shift to Affiliate Marketing in Southeast Asia
Jun 23, 2025 11:00 HKT/SGT
|
|
|
BW Digital and BW ESS launch BW Velora to drive greater digital sustainability
Jun 23, 2025 00:17 HKT/SGT
|
|
|
New method to blend functions for soft electronics
Jun 23, 2025 00:15 HKT/SGT
|
|
|
U Power宣佈在香港投建55座智能換電站 香港首座示範運營智能換電站正式落成
Jun 21, 2025 20:22 HKT/SGT
|
|
|
U Power宣布在香港兴建55座智能换电站 香港首座示范营运智能换电站正式落成
Jun 21, 2025 18:32 HKT/SGT
|
|
|
「数字经济新引擎：以新质生产力推动数字文旅新产业」
Jun 21, 2025 17:09 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
